Clinical Trial Update: Na-Phenylbutyrate VAscular Trial [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) clinical trial evaluating sodium phenylbutyrate for vascular health in individuals with diabetes, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Sodium phenylbutyrate (sodium phenylbutyrate)

Snippet

Sponsor: University of Pennsylvania | Conditions: Diabetes | EARLY_Phase 1 | Status: NOT_YET_RECRUITING